“Endovascular Therapeutics: Developments and Trends in Revascularization Therapies – New Interventional Opportunities” - MIB #002-05

Databases Just Updated!

-- Updates due November 30, 2006 -- including Emerging Technologies & Late Breaking Trials from TCT-06 & the AHA meetings!

Detailed Market Projections!

-- released November 2006!

Detailed Reimbursement Coding Maps!

-- released June 2006!

Now you can have in-depth reporting, analysis and projections at your finger tips. Endovascular Therapeutics reports on the drugs, biological agents, medical devices and systems commercial or in development to treat or prevent restenosis and achieve successful revascularization.

This multi-dimensional, comprehensive tool enables users to quickly navigate this vast market in real-time by searching for products, companies, and clinical trial information on its 3 electronically cross-referenced MIB SMArt Databases™:

• Emerging & Established Technologies - SMArt Chart
• Pivotal Clinical Trials and Registries - SMArt Trials
• Competing Companies - SMArt Companies

This MedIntelliBase™ MarketTrack also contains in-depth and up-to-date MIB Analysis including:

• SMArt Stats - detailed, downloadable and customizable market stats and projections

• SMArt Codes - detailed, downloadable and customizable reimbursement coding maps

• SMArt Volumes™ e-Report, a unique 250-page market report discussing the market, commercial, biological, physiological and clinical issues as well as the rapidly changing and expanding array of interventional modalities now available or being developed to achieve successful revascularization.

Endovascular Therapeutics: Developments and Trends in Revascularization Therapies - New Interventional Opportunities addresses each major modality currently used in peripheral vascular interventions, and offers a unique historical perspective going back to the beginning of interventional medicine.  This MedIntelliBase MarketTrack also examines present and future products, providing information about the specific developments underway by all competitors, large and small, for each modality. We report on:

This exclusive web-based tool is filled with invaluable information and will be continually updated as industry developments occur. 

Our Full EV MedIntelliBase MarketTrack will be available on-line with the purchase of a yearly subscription, via The Next Phase's secure website in later in March.

Available Now - Released Updated November 30 including Emerging Technologies & Late Breaking Trials from TCT-06 & the AHA meetings -- our 3 MIB EV SMArt Databases of rich content.

Yes -  I'd like to see...

detailed Indices of Databases' Contents - Contact the MIB Team>>

Yes - I'd like to see...

sample report pages and database search results - Contact us for Your Real-Time "Customized Tour" of the Coronary Artery MarketTrack - the Endovascular Therapeutics MIB MarketTrack Tour is COMING SOON!

Yes - I'd like to know more about...

New Subscription Options based on my organization's needs!

Order Information on the EV MarketTrack Databases - Available Now!

Or

Order information on the Detailed Market Projections & FULL EV MarketTrack

Or

simply Contact us for Your Real-Time "Customized Tour" to qualify for your 15-day Free Trial!

Last updated November 20, 2006 .

ABOUT US | PUBLISHED PRODUCTS | MEDINTELLIBASE LOGIN | MEDINTELLIGUIDE LOGIN |
Search | Contact | Privacy | Home

The Next Phase Publishing, Inc.
Phone: 425.869.8724 / Fax: 425.869.9397
, to speak with us about our products.
, with questions or comments about this web site.

Copyright © 2007 The Next Phase Publishing, Inc. All rights reserved.